Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2020-06-16 AGM Information
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a notification from Computershare to Canadian Securities Regulatory Authorities regarding an upcoming Annual General Meeting (AGM) for Pharmacielo Ltd. It provides details such as meeting type, record dates, meeting date, location, and proxy material delivery. The document does not contain financial data, management discussion, voting results, or detailed AGM materials but rather serves as an announcement about the AGM logistics. Given the short length (1017 characters) and the nature of the content, this fits best as an AGM Information (AGM-R) filing, which covers presentations and materials shared during the AGM or related announcements about the AGM itself.
2020-06-16 English
Decision Document (Preliminary).PDF
Regulatory Filings Classification · 95% confidence The document is a receipt from the Ontario Securities Commission for the filing of a Preliminary Short Form Prospectus dated June 16, 2020. It is a regulatory acknowledgment of a filing rather than the filing itself. The document is short (918 characters) and serves as confirmation of receipt, not containing financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2020-06-16 English
Qualification certificate.PDF
Regulatory Filings Classification · 95% confidence The document is a Qualification Certificate signed by the CFO of PharmaCielo Ltd. It certifies the company's entitlement to file a short form prospectus under a specific National Instrument and mentions regulatory compliance details. The document is short (1172 characters) and primarily serves as a certification related to regulatory filing requirements rather than containing financial data or report content. It does not present financial statements, management discussion, or detailed report information. Therefore, it fits the criteria for a Regulatory Filing (RNS), which includes officer certifications and attestations related to filings.
2020-06-16 English
Underwriting or agency agreement.PDF
Regulatory Filings
2020-06-16 English
Material change report - French.PDF
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement about PharmaCielo Ltd. entering into an agreement with underwriters to issue new common shares through a public offering, including the number of shares, price, use of proceeds, and regulatory approvals required. It discusses the terms of the offering, the over-allotment option, and the expected closing date. The document also includes a press release and forward-looking statements. There are no financial statements or detailed financial performance data presented. The content focuses on the company's capital raising activity through a share issuance. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a simple notice but a substantive update on financing.
2020-06-16 English
Marketing materials - English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled 'Public Offering of Common Shares' and details the terms and conditions of a treasury offering by PharmaCielo Ltd. It includes specifics such as the number of shares offered, offering price, underwriting details, use of proceeds, lock-up periods, and listing information. The text references a preliminary short form prospectus and the filing of a final short form prospectus, indicating this is a capital raising event. There are no financial statements or earnings data presented, nor is this a regulatory announcement or a report publication notice. The content clearly relates to a financing activity involving issuance of new shares and underwriting arrangements. Therefore, the document fits the category of a Capital/Financing Update (CAP).
2020-06-15 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.